Gilead Sciences, INC Form 4 insider transactions

NASDAQ
Chief Commercial Officer Johanna Mercier reported transactions involving Gilead Sciences common stock and restricted stock units, including acquisitions and disposals related to vesting.
NASDAQ
Andrew Dickinson, CFO of Gilead Sciences, reports transactions involving common stock and restricted stock units, including acquisitions, disposals, and vesting.
NASDAQ
Chief Medical Officer of Gilead Sciences, Merdad Parsey, reports the sale of company stock under a pre-arranged trading plan.